Feedback / Questions
Omvoh (mirikizumab) - Eli Lilly
Mirikizumab: Regulatory submissions in EU/Japan for Crohn's disease in 2024
(Eli Lilly)
-
Feb 6, 2024 -
Q4 2023 Results
EMA filing • Japan filing
•
Crohn's disease • Immunology • Inflammatory Bowel Disease
https://investor.lilly.com/static-files/ecfe166b-dd40-45df-afd7-ddb81fe2cb33
Feb 6, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious